All Stories

  1. Longitudinal changes in bifidobacterial population during the first two years of life
  2. Resource sharing of an infant gut microbiota synthetic community in combinations of human milk oligosaccharides
  3. A synbiotic mixture of selected oligosaccharides and bifidobacteria assists murine gut microbiota restoration following antibiotic challenge
  4. Assessment of infant outgrowth of cow’s milk allergy in relation to the faecal microbiome and metaproteome
  5. Early-life differences in the gut microbiota composition and functionality of infants at elevated likelihood of developing autism spectrum disorder
  6. Quantitative Physiology and Proteome Adaptations of Bifidobacterium breve NRBB57 at Near-Zero Growth Rates
  7. The infant gut microbiota: in pursuit of non-protein nitrogen
  8. Whey-based diet containing medium chain triglycerides modulates the gut microbiota and protects the intestinal mucosa from chemotherapy while maintaining therapy efficacy
  9. Enhanced stress resistance of Bifidobacterium breve NRBB57 by induction of stress proteins at near-zero growth rates
  10. Prenatal diet, plasma micronutrients/metabolome and inflammatory status influence the development of atopic eczema in early childhood
  11. Proof of principle study replicating microbial clusters in connection to birth mode and diet in the early life intestine
  12. Assessment of infant outgrowth of cow’s milk allergy in relation to the faecal microbiome and metaproteome
  13. Altered gut microbiome diversity and function in patients with propionic acidemia
  14. Quantitative physiology and proteome adaptations of Bifidobacterium breve NRBB57 at near-zero growth rates
  15. The Role of the Gut Microbiota in the Effects of Early-Life Stress and Dietary Fatty Acids on Later-Life Central and Metabolic Outcomes in Mice
  16. Early-life fecal microbiome and metabolome dynamics in response to an intervention with infant formula containing specific prebiotics and postbiotics
  17. Effect of antibiotics in the first week of life on faecal microbiota development
  18. Preventive Effect of a Postbiotic and Prebiotic Mixture in a Rat Model of Early Life Rotavirus Induced-Diarrhea
  19. Tolerance development in cow’s milk–allergic infants receiving amino acid–based formula: A randomized controlled trial
  20. The first fungi: mode of delivery determines early life fungal colonization in the intestine of preterm infants
  21. Influence of timing of maternal antibiotic administration during caesarean section on infant microbial colonisation: a randomised controlled trial
  22. The role of the gut microbiota in the effects of early-life stress and dietary fatty acids on later-life central and metabolic outcomes in mice
  23. Early-Life Respiratory Infections in Infants with Cow’s Milk Allergy: An Expert Opinion on the Available Evidence and Recommendations for Future Research
  24. From Mum to Bum: An Observational Study Protocol to Follow Digestion of Human Milk Oligosaccharides and Glycoproteins from Mother to Preterm Infant
  25. Ligilactobacillus salivarius PS2 Supplementation during Pregnancy and Lactation Prevents Mastitis: A Randomised Controlled Trial
  26. Effects of a Postbiotic and Prebiotic Mixture on Suckling Rats’ Microbiota and Immunity
  27. Household environmental microbiota influences early‐life eczema development
  28. A synbiotic intervention modulates meta-omics signatures of gut redox potential and acidity in elective caesarean born infants
  29. A Continuous Battle for Host-Derived Glycans Between a Mucus Specialist and a Glycan Generalist in vitro and in vivo
  30. Maturation of the preterm gastrointestinal tract can be defined by host and microbial markers for digestion and barrier defense
  31. Microbial Glycoside Hydrolases in the First Year of Life: An Analysis Review on Their Presence and Importance in Infant Gut
  32. Broad Purpose Vector for Site-Directed Insertional Mutagenesis in Bifidobacterium breve
  33. Early life antibiotics and childhood gastrointestinal disorders: a systematic review
  34. Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants
  35. Cross-feeding betweenBifidobacterium infantisandAnaerostipes caccaeon lactose and human milk oligosaccharides
  36. Impact of synbiotics on gut microbiota during early life: a randomized, double-blind study
  37. Breast milk urea as a nitrogen source for urease positiveBifidobacterium infantis
  38. Bifidobacterium Transformation
  39. Gut Microbiota of Young Children Living in Four Brazilian Cities
  40. The Bifidogenic Effect Revisited—Ecology and Health Perspectives of Bifidobacterial Colonization in Early Life
  41. Dietary patterns in childhood and their effect on gut microbiota—an Asian perspective on atopy risk
  42. A compromised developmental trajectory of the infant gut microbiome and metabolome in atopic eczema
  43. Bacteroides thetaiotaomicron Fosters the Growth of Butyrate-Producing Anaerostipes caccae in the Presence of Lactose and Total Human Milk Carbohydrates
  44. Enduring Behavioral Effects Induced by Birth by Caesarean Section in the Mouse
  45. Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro
  46. The Infant-Derived Bifidobacterium bifidum Strain CNCM I-4319 Strengthens Gut Functionality
  47. Dynamics of the bacterial gut microbiota in preterm and term infants after intravenous amoxicillin/ceftazidime treatment
  48. Strain-Specific Probiotic Properties of Bifidobacteria and Lactobacilli for the Prevention of Diarrhea Caused by Rotavirus in a Preclinical Model
  49. The Influence of Timing of Maternal Administration of Antibiotics During Caesarean Section on the Intestinal Microbial Colonization in Infants (MAMI-Trial): A Randomized Controlled Trial
  50. Correction: Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice
  51. Microbial transmission from mother to child: improving infant intestinal microbiota development by identifying the obstacles
  52. Low‐calcium diet in mice leads to reduced gut colonization by Enterococcus faecium
  53. Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond
  54. Oligosaccharides Modulate Rotavirus-Associated Dysbiosis and TLR Gene Expression in Neonatal Rats
  55. Short‐term changes of intestinal microbiota composition in preterm infants after two prophylactic doses of vancomycin
  56. Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice
  57. A specific synbiotic-containing amino acid-based formula restores gut microbiota in non-IgE mediated cow’s milk allergic infants: a randomized controlled trial
  58. Gut microbiota from infant with cow’s milk allergy promotes clinical and immune features of atopy in a murine model
  59. Prebiotic oligosaccharides in early life alter gut microbiome development in male mice while supporting influenza vaccination responses
  60. The Preterm Gut Microbiota: An Inconspicuous Challenge in Nutritional Neonatal Care
  61. Metaproteomic and 16S rRNA Gene Sequencing Analysis of the Infant Fecal Microbiome
  62. Supplementation of dietary non-digestible oligosaccharides from birth onwards improve social and reduce anxiety-like behaviour in male BALB/c mice
  63. Mice co-administrated with partially hydrolysed whey proteins and prebiotic fibre mixtures show allergen-specific tolerance and a modulated gut microbiota
  64. Prevention of Rotavirus Diarrhea in Suckling Rats by a Specific Fermented Milk Concentrate with Prebiotic Mixture
  65. A specific synbiotic-containing amino acid-based formula in dietary management of cow’s milk allergy: a randomized controlled trial
  66. The potential for pre-, pro- and synbiotics in the management of infants at risk of cow's milk allergy or with cow's milk allergy: An exploration of the rationale, available evidence and remaining questions
  67. Targeting the gut microbiota to influence brain development and function in early life
  68. The potential role of gut microbiota and its modulators in the management of propionic and methylmalonic acidemia
  69. Sex differences in lipid metabolism are affected by presence of the gut microbiota
  70. Comparative genomics and genotype-phenotype associations in Bifidobacterium breve
  71. A synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V increases faecal Bifidobacterium in healthy young children
  72. Preventive Effect of a Synbiotic Combination of Galacto- and Fructooligosaccharides Mixture With Bifidobacterium breve M-16V in a Model of Multiple Rotavirus Infections
  73. Cross-feeding between Bifidobacterium infantis and Anaerostipes caccae on lactose and human milk oligosaccharides
  74. Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development
  75. Specific synbiotics in early life protect against diet-induced obesity in adult mice
  76. Deciphering the trophic interaction between Akkermansia muciniphila and the butyrogenic gut commensal Anaerostipes caccae using a metatranscriptomic approach
  77. Association between duration of intravenous antibiotic administration and early-life microbiota development in late-preterm infants
  78. Comparative genome and methylome analysis reveals restriction/modification system diversity in the gut commensal Bifidobacterium breve
  79. A synbiotic-containing amino-acid-based formula improves gut microbiota in non-IgE-mediated allergic infants
  80. Ratio of Klebsiella/Bifidobacterium in early life correlates with later development of paediatric allergy
  81. Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B12 Production by Intestinal Symbionts
  82. P35: AMINO ACID-BASED FORMULA WITH SYNBIOTICS MODIFIES GUT MICROBIOTA IN NON-IGE MEDIATED COW’S MILK ALLERGIC INFANTS
  83. Metaproteomics reveals functional differences in intestinal microbiota development of preterm infants
  84. Effect of Synbiotic on the Gut Microbiota of Cesarean Delivered Infants
  85. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis
  86. Intervention strategies for cesarean section–induced alterations in the microbiota-gut-brain axis
  87. Early-life origin of intestinal inflammatory disorders
  88. Gut Microbiota Composition of Non-IgE Mediated Cow's Milk Allergic Infants before and after Dietary Management with a Synbiotics-Supplemented Amino Acid-Based Formula
  89. A fermented milk concentrate and a combination of short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides/pectin-derived acidic oligosaccharides protect suckling rats from rotavirus gastroenteritis
  90. Longitudinal Investigation of Carriage Rates, Counts, and Genotypes of Toxigenic Clostridium difficile in Early Infancy
  91. Human gut microbes impact host serum metabolome and insulin sensitivity
  92. Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota
  93. The Variable Regions ofLactobacillus rhamnosusGenomes Reveal the Dynamic Evolution of Metabolic and Host-Adaptation Repertoires
  94. A combination of scGOS/lcFOS with Bifidobacterium breve M-16V protects suckling rats from rotavirus gastroenteritis
  95. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood–Adulthood Transition
  96. Infant formula containing galacto-and fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study
  97. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
  98. The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5
  99. Multilocus sequence typing of bifidobacterial strains from infant’s faeces and human milk: are bifidobacteria being sustainably shared during breastfeeding?
  100. Similar Occurrence of Febrile Episodes Reported in Non-Atopic Children at Three to Five Years of Age after Prebiotics Supplemented Infant Formula
  101. Carbohydrate utilization genetic signatures in the species Lactobacillus rhamnosus
  102. Fermented Infant Formula Increases Ileal Protein Digestibility and Reduces Ileal Proteolytic Activity Compared with Standard and Hydrolyzed Infant Formulas in Piglets
  103. Preweaning modulation of intestinal microbiota by oligosaccharides or amoxicillin can contribute to programming of adult microbiota in rats
  104. Dietary Pectin–Derived Acidic Oligosaccharides Improve the Pulmonary Bacterial Clearance ofPseudomonas aeruginosaLung Infection in Mice by Modulating Intestinal Microbiota and Immunity
  105. An integrated catalog of reference genes in the human gut microbiome
  106. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes
  107. The first thousand days - intestinal microbiology of early life: establishing a symbiosis
  108. Altered gut microbiota and activity in a murine model of autism spectrum disorders
  109. Mother-to-Infant Transmission of Intestinal Bifidobacterial Strains Has an Impact on the Early Development of Vaginally Delivered Infant's Microbiota
  110. A novel protein mixture containing vegetable proteins renders enteral nutrition products non-coagulating after in vitro gastric digestion
  111. Richness of human gut microbiome correlates with metabolic markers
  112. Relevance of pre- and postnatal nutrition to development and interplay between the microbiota and metabolic and immune systems
  113. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides
  114. The Immunomodulatory Nutritional Intervention NR100157 Reduced CD4+ T-Cell Decline and Immune Activation: A 1-Year Multicenter Randomized Controlled Double-Blind Trial in HIV-Infected Persons Not Receiving Antiretroviral Therapy (The BITE Study)
  115. Human milk: a source of more life than we imagine
  116. Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health
  117. Development of the Digestive System—Experimental Challenges and Approaches of Infant Lipid Digestion
  118. The effect of enteral supplementation of specific neutral and acidic oligosaccharides on the faecal microbiota and intestinal microenvironment in preterm infants
  119. Structure and Catalytic Mechanism of 3-Ketosteroid-Δ4-(5α)-dehydrogenase fromRhodococcus jostiiRHA1 Genome
  120. The Early Settlers: Intestinal Microbiology in Early Life
  121. Improved Detection of Bifidobacteria with Optimised 16S rRNA-Gene Based Pyrosequencing
  122. Galectin-9 induced by dietary synbiotics is involved in suppression of allergic symptoms in mice and humans
  123. A Fermented Infant Milk Formula Reduces Ileal Proteolytic Activity
  124. Effects of a New Prebiotic Mixture on Faecal Gut Microbiota and the Mucosal Immune System in Healthy Infants
  125. Cloning, overexpression, purification, crystallization and preliminary X-ray analysis of 3-ketosteroid Δ4-(5α)-dehydrogenase fromRhodococcus jostiiRHA1
  126. Analysis of infant isolates of Bifidobacterium breve by comparative genome hybridization indicates the existence of new subspecies with marked infant specificity
  127. Transmission of Intestinal Bifidobacterium longum subsp.longumStrains from Mother to Infant, Determined by Multilocus Sequencing Typing and Amplified Fragment Length Polymorphism
  128. Bifidobacterium breve– HT-29 cell line interaction: modulation of TNF-α induced gene expression
  129. Bacterial Translocation Is Reduced by a Specific Nutritional Combination in Mice with Chemotherapy-Induced Neutropenia
  130. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trial
  131. Enterotypes of the human gut microbiome
  132. Early life: gut microbiota and immune development in infancy
  133. 89 The Effect of Enteral Supplementation of Neutral and Acidic Oligosaccharides on Intestinal Microbiota, Ph, Scfas and Siga in Preterm Infants
  134. Bifidobacterium population analysis in the infant gut by direct mapping of genomic hybridization patterns: potential for monitoring temporal development and effects of dietary regimens
  135. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome
  136. Metagenomics of the intestinal microbiota: potential applications
  137. Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers
  138. Effect of multifibre mixture with prebiotic components on bifidobacteria and stool pH in tube-fed children
  139. Intestinal microbiota in allergic and nonallergic 1-year-old very low birth weight infants after neonatal glutamine supplementation
  140. Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response
  141. Gut health: predictive biomarkers for preventive medicine and development of functional foods
  142. A human gut microbial gene catalogue established by metagenomic sequencing
  143. Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial
  144. Exposure of Intestinal Epithelial Cells to UV-Killed Lactobacillus GG but Not Bifidobacterium breve Enhances the Effector Immune Response in vitro
  145. Oral Treatment with Probiotics Reduces Allergic Symptoms in Ovalbumin-Sensitized Mice: A Bacterial Strain Comparative Study
  146. Prebiotics and Probiotics in Infant Formulae
  147. Cow Milk Allergy Symptoms Are Reduced in Mice Fed Dietary Synbiotics during Oral Sensitization with Whey
  148. Mixed-Species Genomic Microarray Analysis of Fecal Samples Reveals Differential Transcriptional Responses of Bifidobacteria in Breast- and Formula-Fed Infants
  149. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients
  150. Fecal Secretory Immunoglobulin A Is Increased in Healthy Infants Who Receive a Formula with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides
  151. 3-Keto-5α-steroid Δ1-dehydrogenase fromRhodococcus erythropolisSQ1 and its orthologue inMycobacterium tuberculosisH37Rv are highly specific enzymes that function in cholesterol catabolism
  152. Prebiotic oligosaccharides and the enterohepatic circulation of bile salts in rats
  153. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project
  154. Carbohydrates in Human Milk and Infant Formulas
  155. Early Impairment of Gut Function and Gut Flora Supporting a Role for Alteration of Gastrointestinal Mucosa in Human Immunodeficiency Virus Pathogenesis
  156. Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity—a randomized, double-blind, placebo-controlled study
  157. The effect of glutamine-enriched enteral nutrition on intestinal microflora in very low birth weight infants: A randomized controlled trial
  158. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1‐dependent vaccination responses in mice
  159. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants
  160. A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model
  161. The intestinal bacterial colonisation in preterm infants: A review of the literature
  162. Transcriptome Analysis Reveals Mechanisms by Which Lactococcus lactis Acquires Nisin Resistance
  163. Bifidogenic Effects of Solid Weaning Foods With Added Prebiotic Oligosaccharides
  164. Quantitative Real-Time PCR Analysis of Fecal Lactobacillus Species in Infants Receiving a Prebiotic Infant Formula
  165. Effects of total enteral nutrition supplemented with a multi-fibre mix on faecal short-chain fatty acids and microbiota
  166. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life
  167. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: A review
  168. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants
  169. Prebiotic carbohydrates in human milk and formulas
  170. Strain-Specific Effects of Probiotics on Gut Barrier Integrity following Hemorrhagic Shock
  171. Quantitative Real-Time PCR Assays To Identify and Quantify Fecal Bifidobacterium Species in Infants Receiving a Prebiotic Infant Formula
  172. The gusBC Genes of Escherichia coli Encode a Glucuronide Transport System
  173. Colon Microflora in Infants Fed Formula with Galacto- and Fructo-Oligosaccharides: More Like Breast-Fed Infants
  174. 134 Effect of Colonic Short Chain Fatty Acids, Lactate and PH on The Growth of Common Gut Pathogens
  175. Prebiotics in Infant Formulas
  176. Prebiotics and Immune Responses
  177. Randomized Double-Blind Study of the Nutritional Efficacy and Bifidogenicity of a New Infant Formula Containing Partially Hydrolyzed Protein, a High β-Palmitic Acid Level, and Nondigestible Oligosaccharides
  178. Development of 16S rRNA-Based Probes for theCoriobacterium Group and the Atopobium Cluster and Their Application for Enumeration of Coriobacteriaceaein Human Feces from Volunteers of Different Age Groups
  179. Rotational Mobility and Orientational Stability of a Transport Protein in Lipid Membranes
  180. Quaternary Structure of the Lactose Transport Protein ofStreptococcus thermophilusin the Detergent-solubilized and Membrane-reconstituted State
  181. Close Approximation of Putative α-Helices II, IV, VII, X, and XI in the Translocation Pathway of the Lactose Transport Protein ofStreptococcus thermophilus
  182. Amplified expression and membrane reconstitution of transport proteins
  183. Detergent-Mediated Reconstitution of Membrane Proteins†
  184. Amplified Expression, Purification and Functional Reconstitution of the Dipeptide and Tripeptide Transport Protein of Lactococcus Lactis
  185. Unidirectional Reconstitution into Detergent-destabilized Liposomes of the Purified Lactose Transport System ofStreptococcus thermophilus
  186. Cation and sugar selectivity determinants in a novel family of transport proteins
  187. Purification and Reconstitution of the Glutamate Carrier GltT of the Thermophilic Bacterium Bacillus stearothermophilus
  188. Kinetic Analysis of Lactose and Proton Coupling in Glu379Mutants of the Lactose Transport Protein ofStreptococcus thermophilus
  189. Regulation of bacterial sugar-H+ symport by phosphoenolpyruvate-dependent enzyme I/HPr-mediated phosphorylation.
  190. Directed genomic integration, gene replacement, and integrative gene expression in Streptococcus thermophilus
  191. A Kdp-like, high-affinity, K+-translocating ATPase is expressed during growth of Rhodobacter sphaeroides in low potassium media